Geron
Mary L Browning is an accomplished medical science liaison with extensive experience in the pharmaceutical industry, currently serving as a Community Medical Science Liaison at Geron Corporation since May 2024. Previous roles include Medical Science Liaison at PharmaEssentia, where responsibilities encompassed supporting drug launch activities and facilitating trial enrollment, as well as a Sr. Medical Science Liaison at Pharmacyclics, focusing on chronic lymphocytic leukemia research. Additional experience includes roles at Shire, Infinity Pharmaceuticals, Sigma Tau Pharmaceuticals, and Geznyme, contributing to clinical trials and providing education to healthcare providers. Prior to entering the pharmaceutical sector, Mary L Browning worked as a Research Nurse Supervisor at U.T. M. D. Anderson Cancer Center, enhancing clinical trial operations. Mary L Browning holds a BS in Nursing and is pursuing a Master of Science in Family Practice Nurse/Nursing at Texas Woman's University.
This person is not in any teams
This person is not in any offices
Geron
4 followers
Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies.